Icariin interacts with IGFBP3 to alleviate diabetic cataract through PI3K/AKT signaling pathway
Diabetic cataract (DC), a well-recognized complication in diabetic patients, can progress to blindness if not adequately managed, with currently limited therapeutic strategies. Icariin (ICA), a natural compound derived from Epimedium, has been demonstrated exhibiting anti-inflammatory and anti-oxidant, but its impact on diabetic cataracts remains elusive. In this study, we used both <i>in vitro</i> SRA01/04 cells and <i>in vivo</i> SD rats' model to explored the protective effects of ICA in cataract formation. Following network pharmacology, proteomic and surface plasmon resonance (SPR) analyses further demonstrated that ICA interacts with insulin-like growth factor-binding protein-3 (IGFBP3) and modulates oxidative stress as well as apoptosis via the PI3K/AKT signaling pathway. These findings collectively demonstrated that ICA could alleviate high glucose-induced oxidative stress and cell apoptosis <i>in vitro</i> and <i>in vivo</i>, suggesting that ICA is a potent natural compound with protective effects in DC, offering an effective therapeutic approach for the disease management.
Authors
- Xiang Gao (ORCID: https://orcid.org/0000-0001-7478-5072)
- Hangjia Zuo
- Shuhao Zeng (ORCID: https://orcid.org/0000-0003-4534-6702)
- Shangze Gao (ORCID: https://orcid.org/0000-0001-5399-6129)
- Fanfan Huang (ORCID: https://orcid.org/0000-0001-8573-3323)
- Shengping Hou (ORCID: https://orcid.org/0000-0002-7796-8891)
- Shijie Zheng
- Tian Meng (ORCID: https://orcid.org/0000-0003-2115-5848)
- Xianyang Liu
- Chao Wu (ORCID: https://orcid.org/0000-0003-0260-2868)
- Yakun Wang (ORCID: https://orcid.org/0000-0003-0568-8783)
- Ke Hu (ORCID: https://orcid.org/0000-0002-1627-7659)
- Fan Cao (ORCID: https://orcid.org/0000-0003-4999-458X)
- Hui Yang (ORCID: https://orcid.org/0000-0002-9162-6951)
- Wenxian Yang (ORCID: https://orcid.org/0000-0003-3736-9832)
- Baorui Chu
- Yongguo Xiang (ORCID: https://orcid.org/0009-0003-5398-1615)
- Hui Feng
- Wenjuan Wan
Institutions
- Beijing Tongren Hospital (CN)
- Capital Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- iScience
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1016/j.isci.2025.112796
- Citations
- 1
- Primary Topic
- Natural product bioactivities and synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- National Natural Science Foundation of China